Variant · Fusion
ABL1 Fusion
CI-VAR-00001251Explore in graph →CIViC 2682
Curated evidence
Evidence by cancer (6 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 31935290
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Acute Lymphoblastic Leukemia1 | ||||||||
| FOXP1::ABL1 Fusion | (diagnostic) | Diagnostic | B | Supports Positive | 3 | rejected | EID9155FOXP1-ABL1 fusion was identified in Ph-like ALL PMID 31935290 · Harvey et al., 2020 · Open in CIViC | civic |
| B Lymphoblastic Leukemia/Lymphoma1 | ||||||||
| FOXP1::ABL1 Fusion | (prognostic) | Prognostic | D | Supports Poor Outcome | 4 | rejected | EID9154This study comprised 127 consecutive patients (age ≥16 years) with newly diagnosed BCP-ALL with available molecular data.The non-response rate, defined as the proportion of patients who had not achiev… (full text at CIViC) PMID 25769542 · Boer et al., 2015 · Open in CIViC | |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available